Friday, April 7 marks the beginning of a year-long campaign by the World Health Organization (WHO) to increase awareness and encourage research and treatment of what is the largest cause of disability worldwide: depression
Obstructive sleep apnea is a common problem affecting a large portion of the population. Today we examine medical cannabis and sleep apnea related research.
Eating disorders are a serious mental health issue for many Canadians today. Today we look at how medical cannabis is being investigated as a potential treatment for this array of conditions.
Today, we’re pleased to announce that we have become the first licensed medical cannabis producer in North America to be GMP certified in accordance with the European Medicines Agency’s good manufacturing practice (GMP) standards.
